Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May;31(3):258-267.
doi: 10.1111/sdi.12694. Epub 2018 Apr 6.

Hemodialysis-induced cardiovascular disease

Shadi Ahmadmehrabi  1 , W H Wilson Tang  2   3   4
Affiliations
Review

Hemodialysis-induced cardiovascular disease

Shadi Ahmadmehrabi et al. Semin Dial. 2018 May.

Abstract

More than half of all deaths among end stage renal disease (ESRD) patients are due to cardiovascular disease (CVD). Cardiovascular changes secondary to renal dysfunction, including fluid overload, uremic cardiomyopathy, secondary hyperparathyroidism, anemia, altered lipid metabolism, and accumulation of gut microbiota-derived uremic toxins like trimethylamine N-oxidase, contribute to the high risk for CVD in the ESRD population. In addition, conventional hemodialysis (HD) itself poses myocardial stress and injury on the already compromised cardiovascular system in uremic patients. This review will provide an overview of cardiovascular changes in chronic kidney disease and ESRD, a description of reported mechanisms for HD-induced myocardial injury, comparison of HD with other treatment modalities in the context of CVD, and possible management strategies.

PubMed Disclaimer

Conflict of interest statement

Disclosure: There are no relationships relevant to this work to disclose.

Figures

Figure 1
Figure 1
Factors affecting hemodynamic-induced cardiovascular disease
See this image and copyright information in PMC

References

    1. US Renal Data System. 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2016. https://www.usrds.org/. Accessed July 28, 2017.
    1. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003;63(3):793–808. doi: 10.1046/j.1523-1755.2003.00803.x. - DOI - PubMed
    1. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis Off J Natl Kidney Found. 1996;28(1):53–61. - PubMed
    1. Levin A, Thompson CR, Ethier J, et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis Off J Natl Kidney Found. 1999;34(1):125–134. doi: 10.1053/AJKD03400125. - DOI - PubMed
    1. Eckardt KU. Anaemia in end-stage renal disease: pathophysiological considerations. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2001;16(Suppl 7):2–8. - PubMed

Publication types

LinkOut - more resources